0001477449-23-000040.txt : 20230906
0001477449-23-000040.hdr.sgml : 20230906
20230906161310
ACCESSION NUMBER: 0001477449-23-000040
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230901
FILED AS OF DATE: 20230906
DATE AS OF CHANGE: 20230906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Murthy Mala
CENTRAL INDEX KEY: 0001780955
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 231239317
MAIL ADDRESS:
STREET 1: C/O TELADOC HEALTH, INC.
STREET 2: 2 MANHATTANVILLE ROAD, SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
wk-form4_1694031174.xml
FORM 4
X0508
4
2023-09-01
0
0001477449
Teladoc Health, Inc.
TDOC
0001780955
Murthy Mala
C/O TELADOC HEALTH, INC.,
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
0
1
0
0
CHIEF FINANCIAL OFFICER
0
Common Stock
2023-09-01
4
M
0
3369
A
48085
D
Common Stock
2023-09-01
4
M
0
2043
A
50128
D
Common Stock
2023-09-05
4
S
0
3221
22.894
D
46907
D
Restricted Stock Units
2023-09-01
4
M
0
3369
0
D
Common Stock
3369
20214
D
Restricted Stock Units
2023-09-01
4
M
0
2043
0
D
Common Stock
2043
14307
D
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
On March 1, 2022, the reporting person was granted 40,426 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
/s/ Adam C. Vandervoort, Attorney-in-Fact
2023-09-06